Mizuho raises Chesapeake Utilities stock price target on growth outlook

Mizuho raised its price target for Chesapeake Utilities (NYSE:CPK) to $155 from $150, citing growth prospects. The company's Q3 2026 EPS of $0.89 missed estimates but revenue grew 14% YoY. Management highlighted strong underlying growth and raised dividends for 23 consecutive years.

Original reporting
Published Nov 9, 2026, 11:52 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 11:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CPK
Bullish
high confidence
Mentioned
$CPK
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CPKBullishMed
01

Why it matters

Analyst upgrade may attract new buying interest despite the earnings miss.

02

Market read

The price target raise provides a fresh catalyst for CPK, potentially influencing short-term trading decisions.

03

What to watch

Potential headwinds from rising payroll costs and healthcare claims may limit upside.

Relevance 7/10Novelty 8/10Timing: today

Background

Chesapeake Utilities reported Q3 2026 adjusted EPS of $0.89, missing consensus, but revenue grew 14% YoY.

Company-level read

Ticker impact

$CPKBullishHigh confidence
Context

Mizuho raised its price target on Chesapeake Utilities (CPK) to $155 from $150 following the company's Q3 earnings miss.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target is above current price and reflects confidence in growth despite earnings miss.

Market effects

Utility sector may see modest uplift as analyst upgrades could spill over to peers.

U.S. equity market may see slight positive bias in the utilities segment.

Limited to U.S. investors; no global macro effect.

Counterpoint

The earnings miss and higher expenses could signal underlying weakness, making the target raise premature.

Key entities

  • Mizuho

    Raised price target and maintained Outperform rating.

  • Chesapeake Utilities Corp.

    Utility company with mixed Q3 results.

Related articles

$CPKMed

Chesapeake Utilities Q3 Earnings Call Highlights

Chesapeake Utilities (CPK) reported Q3 earnings, highlighting contracts with three anchor shippers for 250,000 dekatherms per day. The company expects a $125M Worcester Resiliency Upgrade facility to come online in Q1 2027, with adjusted margins. Florida rate case decisions are expected in early 2027. The company plans to issue $250M in long-term debt and reaffirmed 2028 EPS guidance of $7.75-$8.00.

$CPKMed

Chesapeake Utilities Corp (CPK) (Q3 2026) Earnings Call Highlights: Double-Digit Net

Chesapeake Utilities Corp (CPK) reported Q3 2026 earnings, citing higher costs that reduced adjusted EPS by $0.12. The company faced increased O&M expenses, depreciation, and property taxes. The WRU project's capital investment rose to $125M. CEO Jeff Householder discussed growth prospects, regulatory uncertainty, and margin dynamics. The company remains optimistic about future projects and cost management.

$CPKMed

Chesapeake Util (CPK) Q3 2026 Earnings Call Transcript

Chesapeake Util (CPK) reported Q3 2026 earnings with a 12% increase in adjusted net income and 8% rise in adjusted earnings per share. The company invested $151M in capital, on track for $550M-$600M annual guidance. Customer growth and infrastructure projects, including the $1.2B Florida Energy Pathway, drive long-term strategy. FCG rate case interim rates contributed $2.7M in margin.

$CPKHighAI 8/10

Chesapeake Util (CPK) Q3 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q3 2026 earnings with adjusted EPS of $0.89, up 9%, and adjusted net income of $21.6M, up 11%. Growth was driven by natural gas projects and regulatory initiatives. Capital investment reached $151.2M, on track for annual targets. Management highlighted long-term growth prospects and reaffirmed 2028 EPS guidance of $7.75-$8.00. Risks include higher healthcare costs and increased project expenses.